Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Xinkai Pharmaceutical Chemical is a specialized manufacturer and developer of pharmaceutical intermediates and fine chemicals based in China. Established in 1994, the company focuses on the synthesis of complex organic molecules, particularly nucleoside analogs and antiviral agents. They provide custom synthesis and contract manufacturing services to global pharmaceutical and biotech companies. Their product portfolio includes a wide range of intermediates used in the production of active pharmaceutical ingredients (APIs). The company operates R&D facilities and manufacturing sites that adhere to industry quality standards. They are recognized for their technical expertise in multi-step organic synthesis and high-pressure reactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 欣凯医药化工中间体.